Board of directors (11)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (6)
Company facts
- Chair
- Aart De Geus
- In S&P 500 since
- Mar 2017
- Incorporated in
- DE
- Fiscal year ends
- October
- SEC industry
- Services-Prepackaged Software
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Sassine Ghazi PRESIDENT AND CEO | Sale | 14,604 | $462.84 | $6.8M |
| Oct 6, 2026 | Janet Lee GC & Corporate Secretary | Sale | 584 | $502.64 | $293K |
| Oct 6, 2026 | Janet Lee GC & Corporate Secretary | Sale | 560 | $502.40 | $281K |
| Oct 6, 2026 | Sudhindra Kankanwadi Deputy CFO & CAO | Sale | 9,170 | $500.00 | $4.6M |
| Oct 5, 2026 | Sudhindra Kankanwadi Deputy CFO & CAO | Sale | 3,000 | $484.78 | $1.5M |
| Sep 15, 2026 | Sassine Ghazi PRESIDENT AND CEO | Sale | 14,604 | $374.88 | $5.5M |
| Sep 1, 2026 | Aart De Geus EXECUTIVE CHAIR | Sale | 24,641 | $419.44 | $10.3M |
| Aug 31, 2026 | Aart De Geus EXECUTIVE CHAIR | Sale | 25,000 | $441.76 | $11.0M |
| Aug 28, 2026 | Aart De Geus EXECUTIVE CHAIR | Sale | 25,000 | $445.55 | $11.1M |
| Jun 15, 2026 | Sassine Ghazi PRESIDENT AND CEO | Sale | 14,603 | $458.96 | $6.7M |
| Jun 12, 2026 | Shelagh Glaser CFO | Sale | 3,394 | $450.02 | $1.5M |
| Jan 12, 2026 | Janet Lee GC & Corporate Secretary | Sale | 250 | $530.00 | $133K |
| Jan 7, 2026 | Janet Lee GC & Corporate Secretary | Sale | 250 | $510.00 | $128K |
| Dec 19, 2025 | Shelagh Glaser CFO | Sale | 2,613 | $460.77 | $1.2M |
| Dec 19, 2025 | Shelagh Glaser CFO | Sale | 1,044 | $460.77 | $481K |
| Sep 22, 2025 | Sudhindra Kankanwadi Deputy CFO & CAO | Sale | 9,873 | $500.90 | $4.9M |
| Sep 19, 2025 | Sudhindra Kankanwadi Deputy CFO & CAO | Sale | 6,000 | $482.00 | $2.9M |
| Sep 11, 2025 | Robert G. Painter Director | Buy | 350 | $425.44 | $149K |
| Sep 5, 2025 | Shelagh Glaser CFO | Sale | 1,043 | $609.77 | $636K |
| Sep 5, 2025 | Shelagh Glaser CFO | Sale | 2,612 | $609.77 | $1.6M |
| Sep 2, 2025 | Sassine Ghazi PRESIDENT AND CEO | Sale | 11,366 | $589.01 | $6.7M |
| Jun 18, 2025 | Richard S. Mahoney Chief Revenue Officer | Sale | 2,949 | $471.27 | $1.4M |
| Jun 18, 2025 | Richard S. Mahoney Chief Revenue Officer | Sale | 4,869 | $471.19 | $2.3M |
| Jun 18, 2025 | Richard S. Mahoney Chief Revenue Officer | Sale | 1,192 | $471.18 | $562K |
| Jun 6, 2025 | Shelagh Glaser CFO | Sale | 2,086 | $485.72 | $1.0M |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Aug 12, 2026
On August 12, 2026, Synopsys, Inc. (“ Synopsys ”) announced that Janet Lee will no longer serve as Synopsys’ General Counsel and Corporate Secretary, effective as of the earlier of (i) December 31, 2026, and (ii) the appointment of her successor. Thereafter, Ms. Lee will transition to an advisory role and will continue in that role until June 30, 2027, or such later date as determined by Synopsys, to ensure a smooth transition.
Read the 8-K filing - May 27, 2026
by reference. There are no arrangements or understandings between Mr. Cohn and any other person pursuant to which Mr. Cohn was appointed as a director, other than with respect to the matters referred to in
Read the 8-K filing - Apr 20, 2026
(e) Approval of Amended and Restated Equity Incentive Plan At the 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 16, 2026, Synopsys’ stockholders approved Synopsys’ Amended and Restated Equity Incentive Plan (the “ Equity Incentive Plan ”), in order to, among other things, include Synopsys’ non-employee directors as persons eligible to receive awards under the Equity Incentive Plan. Synopsys’ Board of Directors (the “ Board ”) and the Compensation and Organizational Development Committee of the Board previously approved the Equity Incentive Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Equity Incentive Plan.
Read the 8-K filing - Feb 19, 2026
On February 14, 2026, in accordance with the applicable provisions of the amended and restated bylaws of Synopsys, Inc., a Delaware corporation (“ Synopsys ”), the Board of Directors (the “ Board ”) of Synopsys increased the size of the Board from eleven to twelve directors and appointed Peter A. Shimer to serve as a director and as a member of the Audit Committee, effective immediately. The Board has determined that Mr.
Read the 8-K filing - Nov 4, 2025
On November 4, 2025, Synopsys, Inc. (“ Synopsys ”) announced that Rick Mahoney will no longer serve as Synopsys’ Chief Revenue Officer, effective immediately. Synopsys is in advanced stages of its search and expects to announce a replacement shortly.
Read the 8-K filing - Sep 18, 2025
” of the Original 8-K to include additional disclosure regarding Mr. Vijayaraghavan’s appointment to a committee of Synopsys’ Board of Directors (the “ Board ”). No other changes are being made to the Original 8-K.
Read the 8-K filing - Jul 17, 2025
On July 17, 2025, in accordance with the applicable provisions of Synopsys’ amended and restated bylaws, the Board of Directors (the “ Board ”) of Synopsys increased the size of the Board from nine to eleven directors and, pursuant to the Merger Agreement, appointed Dr. Ajei Gopal and Ravi Vijayaraghavan to serve as directors effective as of the Effective Time. Dr. Gopal and Mr. Vijayaraghavan have not been appointed to serve on any committees. Dr. Gopal served as President and Chief Executive Officer of Ansys from 2017 and on Ansys’ board of directors from 2011 until Ansys’ acquisition by Synopsys. Dr. Gopal also served as President and Chief Operating Officer of Ansys in 2016. From 2013 to 2016, Dr. Gopal was an operating partner at Silver Lake, a leading private equity technology investor.
Read the 8-K filing - Apr 11, 2025
(e) Amendment of 2006 Employee Equity Incentive Plan, as amended ; Amendment of Employee Stock Purchase Plan, as amended At the 2025 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 10, 2025, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other things, (i) increase the number of shares of common stock, par value of $0.01 per share, available for issuance under the plan by 1,600,000 shares, (ii) conform the plan to Synopsys’ non-GAAP financial measures practices and compensation recovery policy, as currently effective, and (iii) remove certain references to Section 162(m) of the Internal Revenue Code that are no longer applicable.
Read the 8-K filing - Apr 12, 2024
(e) Amendment of 2006 Employee Equity Incentive Plan, as amended At the 2024 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 10, 2024, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, (i) increase the number of shares of common stock available for issuance under the plan by 3,400,000 shares, (ii) eliminate the term of the plan, and (iii) provide that incentive stock options may be granted without stockholder approval until the ten-year anniversary of the Board of Directors’ (the “ Board ”) approval of the plan. Synopsys’ Board and the Compensation and Organizational Development Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval.
Read the 8-K filing - Dec 21, 2023
” of the Original 8-K to include additional disclosure regarding Sassine Ghazi’s and Aart J. de Geus’ compensation arrangements that were not determined or available at the time of the Original 8-K. No other changes are being made to the Original 8-K.
Read the 8-K filing - Sep 1, 2023
” of the Original 8-K to include additional disclosure regarding Mr. Painter’s appointment to a committee of Synopsys’ Board of Directors (the “ Board ”). No other changes are being made to the Original 8-K.
Read the 8-K filing - Aug 16, 2023
On August 12, 2023, Aart J. de Geus informed the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) of his intent to step down as Chief Executive Officer of Synopsys, effective January 1, 2024 (the “ Effective Date ”). In connection therewith, on August 13, 2023, the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer, and appointed Dr. de Geus to the role of Executive Chair of the Board, in each case, effective as of the Effective Date. On August 13, 2023, the Board also approved an increase in the size of the Board from ten to eleven directors, and appointed Mr. Ghazi as a director, in each case, effective as of August 13, 2023. Mr. Ghazi, 53, has served as our Chief Operating Officer since August 2020 and became our President in November 2021. Mr.
Read the 8-K filing - Aug 7, 2023
(d) Election of Director On August 4, 2023, in accordance with the applicable provisions of its amended and restated bylaws, the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from nine to ten directors and appointed Robert Painter to serve as director effective immediately. The Board has determined that Mr. Painter qualifies as an independent director in accordance with the listing requirements and rules of the Nasdaq Stock Market LLC and Synopsys’ Corporate Governance Guidelines. The Board expects to appoint Mr. Painter to one or more committees of the Board at a later date. Mr. Painter has served as President and Chief Executive Officer of Trimble Inc. (“ Trimble ”), a global, industrial technology company, and on Trimble’s board of directors since January 2020.
Read the 8-K filing - Apr 14, 2023
(e) Amendment of 2006 Employee Equity Incentive Plan At the 2023 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 12, 2023, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the Amended Employee Equity Plan by 3,300,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation and Organizational Development Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Nov 29, 2022
(c) On November 28, 2022, the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) appointed Shelagh Glaser as Chief Financial Officer of Synopsys, effective as of December 2, 2022 (the “ Effective Date ”). In connection with her appointment, Ms. Glaser received an offer letter, which she executed on November 23, 2022 (the “ Offer Letter ”). Trac Pham will cease serving as Chief Financial Officer of Synopsys, effective as of the Effective Date, and will continue in an executive advisor role through December 2022 to ensure an orderly transition. Ms. Glaser, age 58, was previously Chief Financial Officer of Zendesk, Inc., a software-as-a-service company, from May 2021 to November 2022. Prior to that, she served in senior finance roles at Intel Corporation, a multinational technology company, from July 1992 to May 2021.
Read the 8-K filing
Show 20 older changes
- May 25, 2022
(d) Election of Director On May 23, 2022, in accordance with the applicable provisions of its amended and restated bylaws, the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately. The Board has determined that each Appointee qualifies as an independent director in accordance with the listing requirements and rules of the Nasdaq Stock Market LLC and Synopsys’ Corporate Governance Guidelines. The Board expects to appoint each of the Appointees to one or more committees of the Board at a later date. Mr. Borgen served as Chief Financial Officer of athenahealth, Inc. (“ athena ”), a provider of cloud-based healthcare products and services, from September 2019 to April 2022.
Read the 8-K filing - May 19, 2022
On May 13, 2022, Joseph Logan notified Synopsys, Inc. of his decision to transition from his role as Chief Revenue Officer at the conclusion of fiscal year 2022. Following such date, Mr. Logan will continue in an executive advisory role until the end of the first quarter of fiscal year 2023.
Read the 8-K filing - Apr 15, 2022
(e) Amendment of 2006 Employee Equity Incentive Plan; Amendment of Employee Stock Purchase Plan At the 2022 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 12, 2022, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”) in order to, among other items, increase the number of shares of common stock available for issuance under the Amended Employee Equity Plan by 3,000,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation and Organizational Development Committee (the “ Compensation Committee ”) of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Dec 6, 2021
Amended and Restated Executive Incentive Plan On December 3, 2021, the Compensation and Organizational Development Committee (the “ Committee ”) of the Board of Directors (the “ Board ”) of Synopsys, Inc. (the “ Company ”) approved an amendment and restatement of the Company’s Executive Incentive Plan (the “ EIP ” and, as amended, the “ Amended EIP ”), which provides for cash incentive awards and is applicable to officers of the Company as such term is defined in Rule 16a-1(f) under Section 16 of the Securities Exchange Act of 1934, as amended.
Read the 8-K filing - Dec 1, 2021
On November 28, 2021, Trac Pham notified Synopsys, Inc. (“ Synopsys ”) that he intends to retire as Chief Financial Officer of Synopsys in 2022.
Read the 8-K filing - Sep 13, 2021
On September 13, 2021, the Board of Directors of Synopsys, Inc. (“ Synopsys ”) appointed Sassine Ghazi, currently Chief Operating Officer of Synopsys, as President and Chief Operating Officer of Synopsys, effective as of November 1, 2021. Mr. Ghazi, age 51, joined Synopsys in March 1998 as an Application Engineer, and prior to his appointment as Chief Operating Officer, served as General Manager of the Design Group. Prior to joining Synopsys, Mr. Ghazi was a design engineer at Intel. Mr. Ghazi received his bachelor’s degree in Business Administration from Lebanese American University; a B.S.E.E from the Georgia Institute of Technology in 1993; and an M.S.E.E. from the University of Tennessee in 1995. There are no arrangements or understandings between Mr. Ghazi and any other persons pursuant to which Mr. Ghazi was named an officer of Synopsys. Mr.
Read the 8-K filing - May 3, 2021
On April 30, 2021, the Compensation and Organizational Development Committee of the Board of Directors of Synopsys, Inc. (the “ Company ”) approved a $2.775 million relocation assistance payment to Sassine Ghazi, the Company’s Chief Operating Officer, pursuant to a Relocation Assistance Agreement (the “ Relocation Agreement ”) to incentivize him to relocate to the San Francisco Bay Area, where the Company is headquartered. Such payment is subject to repayment by Mr. Ghazi if (i) the Company terminates his employment for cause or he resigns other than for good reason prior to December 31, 2023, pro-rated based on Mr. Ghazi’s termination date, or (ii) he fails to relocate by October 31, 2021.
Read the 8-K filing - Apr 12, 2021
(e) Amendment of 2006 Employee Equity Incentive Plan At the 2021 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 8, 2021, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the Amended Employee Equity Plan by 4,700,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Feb 9, 2021
On February 8, 2021, the Compensation Committee (the “ Committee ”) of the Board of Directors of Synopsys, Inc. (the “ Company ”) approved the Synopsys, Inc. Executive Severance Benefit and Transition Plan (the “ Severance Plan ”) to offer severance benefits to designated key employees outside of a change of control. Each of our current executive officers is covered under the Severance Plan, except Drs. de Geus and Chan. The Severance Plan provides that in the event a participant is terminated without cause or resigns for good reason, such participant shall be entitled to (i) a cash severance payment equal to (a) 12 months of his or her base salary and (b) the cost of 12 months of COBRA premiums, and (ii) six months of vesting acceleration of his or her equity awards that remain subject only to time-based vesting conditions.
Read the 8-K filing - Sep 4, 2020
(d) Election of Director On August 31, 2020, in accordance with the applicable provisions of its bylaws, the Board of Directors (the “ Board ”) of Synopsys increased the size of the Board from nine to ten directors and appointed Jeannine Sargent to serve as a director effective as of September 2, 2020. The Board expects to appoint Ms. Sargent to one or more committees of the Board at a later date. Ms. Sargent currently serves in investment advisory roles that are focused on industries ranging from AI solutions to energy and sustainability. She previously served as president of Innovation and New Ventures at Flex from 2012 to 2017. Before joining Flex, Ms. Sargent served as CEO of Oerlikon Solar and Voyan Technology. There are no arrangements or understandings between Ms. Sargent and any other persons pursuant to which Ms. Sargent was named a director of Synopsys. Ms.
Read the 8-K filing - Aug 19, 2020
(d) Appointment of Principal Operating Officer On August 17, 2020, Sassine Ghazi was promoted to Chief Operating Officer of Synopsys, Inc. (“ Synopsys ”) and was appointed by Synopsys’ Board of Directors as its principal operating officer, effective immediately. Mr. Ghazi, age 50, joined Synopsys in March 1998 as an Application Engineer and most recently served as General Manager of the Design Group. Prior to joining Synopsys, Mr. Ghazi was a design engineer at Intel. Mr. Ghazi received his bachelor’s degree in Business Administration from Lebanese American University; a B.S.E.E from the Georgia Institute of Technology in 1993; and an M.S.E.E. from the University of Tennessee in 1995. There are no arrangements or understandings between Mr. Ghazi and any other persons pursuant to which Mr. Ghazi was named an officer of Synopsys. Mr.
Read the 8-K filing - Apr 15, 2020
(e) Amendment of 2006 Employee Equity Incentive Plan; Amendment of Employee Stock Purchase Plan At the 2020 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 9, 2020, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the plan by 3,500,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Apr 9, 2019
(e) Amendment of 2006 Employee Equity Incentive Plan At the 2019 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 8, 2019, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the plan by 3,200,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Apr 6, 2018
(e) Amendment of 2006 Employee Equity Incentive Plan; Amendment of Employee Stock Purchase Plan At the 2018 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 5, 2018, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the plan by 3,000,000. Synopsys’ Board of Directors (the “ Board ”) and the Compensation Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Dec 14, 2017
On December 8, 2017, Deborah A. Coleman notified Synopsys, Inc. (“ Synopsys ”) of her decision not to stand for re-election to Synopsys’ Board of Directors at Synopsys’ 2018 Annual Meeting of Stockholders (the “ 2018 Annual Meeting ”). Ms. Coleman will continue to serve as a director and audit committee chairperson of Synopsys until the election of directors at the 2018 Annual Meeting. Ms. Coleman’s decision to resign was not the result of any disagreement with Synopsys on any matter.
Read the 8-K filing - Apr 10, 2017
(e) Amendment of 2006 Employee Equity Incentive Plan; Approval of 2017 Non-Employee Directors Equity Incentive Plan At the 2017 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 6, 2017, Synopsys’ stockholders approved Synopsys’ 2006 Employee Equity Incentive Plan, as amended (the “ Amended Employee Equity Plan ”), in order to, among other items, increase the number of shares of common stock available for issuance under the plan by 5,000,000 shares. Synopsys’ Board of Directors (the “ Board ”) and the Compensation Committee of the Board previously approved the Amended Employee Equity Plan, subject to such stockholder approval. Synopsys’ executive officers are eligible to participate in the Amended Employee Equity Plan.
Read the 8-K filing - Feb 15, 2017
(d) Election of Director On February 14, 2017, the Board of Directors (the “ Board ”) of Synopsys increased the size of the Board from ten to eleven directors and appointed Mercedes Johnson to serve as both a director and an Audit Committee member effective on such date. Ms. Johnson previously served as Chief Financial Officer of Avago Technologies, Inc. from 2005 to 2008, and Senior Vice President, Finance and Chief Financial Officer of Lam Research Corporation from 1997 to 2004. Ms. Johnson will participate in Synopsys’ standard non-employee director compensation arrangements, under which she will receive an annual cash retainer of $125,000 payable in advance in quarterly installments. Ms. Johnson will also receive equity awards as provided by Synopsys’ 2005 Non-Employee Directors Equity Incentive Plan (the “ Directors Plan ”).
Read the 8-K filing - Jan 30, 2017
On January 27, 2017, Brian Beattie, Executive Vice President of Business Operations and Chief Administrative Officer of Synopsys, Inc. (“ Synopsys ”), informed Synopsys of his intention to retire effective December 22, 2017. Beginning May 1, 2017, Mr. Beattie will relinquish his duties as an executive officer, at which time he will transition into an executive advisory position for the remainder of his tenure. Synopsys has issued a press release announcing Mr. Beattie’s retirement. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Read the 8-K filing - Sep 7, 2016
On August 31, 2016, Alfred Castino notified Synopsys, Inc. (“ Synopsys ”) of his decision not to stand for re-election to Synopsys’ Board of Directors at Synopsys’ 2017 Annual Meeting of Stockholders (the “ 2017 Annual Meeting ”). Mr. Castino will continue to serve as a director and audit committee member of Synopsys until the election of directors at the 2017 Annual Meeting. Mr. Castino’s decision to resign was not the result of any disagreement with Synopsys on any matter.
Read the 8-K filing - Apr 1, 2016
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $7.1B | $1.3B | 18.9% | $8.04 | $48.2B |
| FY2024 | $6.1B | $2.3B | 36.9% | $14.51 | $13.1B |
| FY2023 | $5.3B | $1.2B | 23.1% | $7.92 | $10.3B |
| FY2022 | $5.1B | $984.6M | 19.4% | $6.29 | $9.4B |
| FY2021 | $4.2B | $757.5M | 18.0% | $4.81 | $8.8B |
| FY2020 | $3.7B | $664.3M | 18.0% | $4.27 | $8.0B |
| FY2019 | $3.4B | $532.4M | 15.8% | $3.45 | $6.4B |
| FY2018 | $3.1B | $432.5M | 13.9% | $2.82 | $6.1B |
Former directors and officers (14)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.